Status:
RECRUITING
New Orleans Pulmonary Hypertension Biobank
Lead Sponsor:
Louisiana State University Health Sciences Center in New Orleans
Conditions:
Pulmonary Hypertension
Systemic Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
Pulmonary hypertension (PH) is a serious condition characterized by a mean pulmonary artery pressure \>=25mmHg on right heart catheterization (RHC). Despite advances in PH care, outcomes are still sub...
Eligibility Criteria
Inclusion
- Diagnosis of pulmonary hypertension and followed at the Comprehensive Pulmonary Hypertension Center OR
- Diagnosis of systemic sclerosis and followed at the Comprehensive Pulmonary Hypertension Center OR
- Diagnosis of mixed connective tissue disease and followed at the Comprehensive Pulmonary Hypertension Center OR
- Undergoing outpatient right heart catheterization
Exclusion
- Age\<18
- Pregnant
- Unable to understand English
- Currently incarcerated
- Unwilling or unable to sign informed consent
Key Trial Info
Start Date :
December 29 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2027
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT03269630
Start Date
December 29 2017
End Date
October 1 2027
Last Update
September 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center-New Orleans
New Orleans, Louisiana, United States, 70112